MetaCap

Tango Therapeutics Insider Trades

NASDAQ: TNGXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

23.81+1.24 (+5.49%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
26 · $12.54M
Shares bought / sold
0 / 858.95K
Net activity
Net selling $12.5 million

Tango Therapeutics insider activity

Over the last 12 months, Tango Therapeutics insiders reported 47 transactions on SEC Form 4: 0 open-market purchases and 26 sales. Insiders bought $0 and sold $12.5 million worth of stock, for net insider selling of $12.5 million. The largest seller was Crystal Adam, with $7.0 million in reported sales.

The most recent filing shows Crystal Adam (President, R&D) reporting a transaction in 27,000 shares at $5.20 on Oct 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TNGX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TNGX insider transactions

Tango Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Oct 1, 2026Crystal AdamPresident, R&DSale600$15.19KForm 4
Oct 1, 2026Crystal AdamPresident, R&DSale26,400$645.60KForm 4
Oct 1, 2026Crystal AdamPresident, R&DOption exercise27,000$140.40KForm 4
Sep 22, 2026Newcomb JessicaPrincipal Accounting OfficerSale2,400$60.41KForm 4
Sep 22, 2026Newcomb JessicaPrincipal Accounting OfficerSale5,100$122.24KForm 4
Sep 22, 2026Newcomb JessicaPrincipal Accounting OfficerSale700$15.96KForm 4
Sep 1, 2026Crystal AdamPresident, R&DSale27,000$603.91KForm 4
Sep 1, 2026Crystal AdamPresident, R&DOption exercise27,000$140.40KForm 4
Aug 3, 2026Crystal AdamPresident, R&DSale21,733$594.42KForm 4
Aug 3, 2026Crystal AdamPresident, R&DSale5,267$141.10KForm 4
Aug 3, 2026Crystal AdamPresident, R&DOption exercise27,000$140.40KForm 4
Jul 1, 2026Crystal AdamPresident, R&DSale7,371$222.95KForm 4
Jul 1, 2026Crystal AdamPresident, R&DSale19,629$575.96KForm 4
Jul 1, 2026Crystal AdamPresident, R&DOption exercise27,000$140.40KForm 4
Jun 19, 2026Azelby RobertDirectorAward5,740—Form 4
Jun 5, 2026Calhoun Lesley AnnDirectorAward4,000—Form 4
Jun 5, 2026Lee SungDirectorAward570—Form 4
Jun 5, 2026Rothenberg MaceDirectorAward4,000—Form 4
Jun 5, 2026Ketchum John BDirectorAward4,000—Form 4
Jun 1, 2026Crystal AdamPresident, R&DSale20,860$480.94KForm 4
Jun 1, 2026Crystal AdamPresident, R&DSale6,140$136.63KForm 4
Jun 1, 2026Crystal AdamPresident, R&DOption exercise27,000$140.40KForm 4
May 1, 2026Gall MatthewChief Financial OfficerAward40,000—Form 4
May 1, 2026Crystal AdamPresident, R&DSale1,100$24.20KForm 4
May 1, 2026Crystal AdamPresident, R&DSale25,900$548.90KForm 4
May 1, 2026Crystal AdamPresident, R&DOption exercise27,000$140.40KForm 4
Apr 29, 2026Lee SungDirectorAward12,300—Form 4
Apr 15, 2026Crystal AdamPresident, R&DSale38,460$961.50KForm 4
Apr 15, 2026Crystal AdamPresident, R&DOption exercise38,460$199.99KForm 4
Apr 1, 2026Crystal AdamPresident, R&DSale27,000$572.48KForm 4
Apr 1, 2026Crystal AdamPresident, R&DOption exercise27,000$140.40KForm 4
Mar 25, 2026Crystal AdamPresident, R&DSale12,000$241.32KForm 4
Mar 25, 2026Crystal AdamPresident, R&DOption exercise12,000$62.40KForm 4
Mar 5, 2026Crystal AdamPresident, R&DSale20,251$303.76KForm 4
Feb 25, 2026Crystal AdamPresident, R&DSale54,345$694.21KForm 4
Feb 3, 2026Crystal AdamPresident, R&DSale201$2.59KForm 4
Feb 3, 2026Crystal AdamPresident, R&DSale18,251$223.71KForm 4
Feb 3, 2026Beckman DaniellaChief Financial OfficerSale113$1.46KForm 4
Feb 3, 2026Beckman DaniellaChief Financial OfficerSale10,204$125.07KForm 4
Feb 3, 2026Weber BarbaraDirector, Executive ChairSale333$4.29KForm 4
Feb 3, 2026Weber BarbaraDirector, Executive ChairSale30,186$370.00KForm 4
Feb 2, 2026Crystal AdamPresident, R&DAward47,460—Form 4
Feb 2, 2026Beckman DaniellaChief Financial OfficerAward44,330—Form 4
Feb 2, 2026Weber BarbaraDirector, Executive ChairAward37,522—Form 4
Jan 8, 2026Peters MaltePresident & CEOAward350,000—Form 4
Jan 2, 2026Lee SungDirectorAward10,000—Form 4
Oct 23, 2025Third Rock Ventures IV, L.P. & Third Rock Ventures GP IV, L.P. & TRV GP IV, LLC10% OwnerSale477,401$4.85MForm 4
Sep 25, 2025Third Rock Ventures IV, L.P. & Third Rock Ventures GP IV, L.P. & TRV GP IV, LLC10% OwnerSale500,000$4.01MForm 4
Sep 16, 2025Third Rock Ventures IV, L.P. & Third Rock Ventures GP IV, L.P. & TRV GP IV, LLC10% OwnerSale363,541$2.56MForm 4
Sep 8, 2025Third Rock Ventures IV, L.P. & Third Rock Ventures GP IV, L.P. & TRV GP IV, LLC10% OwnerSale86,459$608.63KForm 4
Sep 5, 2025Third Rock Ventures IV, L.P. & Third Rock Ventures GP IV, L.P. & TRV GP IV, LLC10% OwnerSale642,906$4.50MForm 4
Aug 22, 2025Third Rock Ventures IV, L.P. & Third Rock Ventures GP IV, L.P. & TRV GP IV, LLC10% OwnerSale302,194$2.12MForm 4
Aug 19, 2025Third Rock Ventures IV, L.P. & Third Rock Ventures GP IV, L.P. & TRV GP IV, LLC10% OwnerSale1,100,000$7.71MForm 4
Jun 5, 2025Borisy AlexisDirectorAward6,250—Form 4
Jun 5, 2025Ketchum John BDirectorAward6,250—Form 4
Jun 5, 2025Rothenberg MaceDirectorAward6,250—Form 4
Jun 5, 2025Peters MalteDirectorAward6,250—Form 4
Jun 5, 2025Calhoun Lesley AnnDirectorAward6,250—Form 4
Feb 5, 2025Barry DouglasGeneral CounselSale2,556$8.08KForm 4
Feb 5, 2025Weber BarbaraChief Executive OfficerSale9,013$28.49KForm 4
Feb 5, 2025Crystal AdamSee RemarksSale6,851$21.66KForm 4
Feb 5, 2025Beckman DaniellaChief Financial OfficerSale3,948$12.48KForm 4
Feb 4, 2025Barry DouglasGeneral CounselSale2,774$8.29KForm 4
Feb 4, 2025Weber BarbaraChief Executive OfficerSale9,778$29.22KForm 4
Feb 4, 2025Crystal AdamSee RemarksSale7,432$22.21KForm 4
Feb 4, 2025Beckman DaniellaChief Financial OfficerSale4,284$12.80KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related